In addition, a hybrid peptide (IL-4Rα-lytic) and cytotoxic cleavage peptide, which bind IL-4Rα, showed anticancer effects in PC cells expressing IL-4Rα and in xenograft mouse models (118). Here, IL4R is linked to pachyonychia congenita.